Rahlfs Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.1M Sell
8,600
-300
-3% -$69.9K 1.54% 17
2025
Q4
$1.84M Hold
8,900
1.43% 21
2025
Q3
$1.65M Sell
8,900
-500
-5% -$85.7K 1.31% 22
2025
Q2
$1.44M Sell
9,400
-711
-7% -$109K 1.31% 21
2025
Q1
$1.68M Hold
10,111
1.68% 15
2024
Q4
$1.46M Buy
+10,111
New +$1.57M 1.45% 20

Other funds holding JNJ

Rahlfs Capital's JNJ Position: Q1 2026 in Review

Rahlfs Capital reduced its Johnson & Johnson (JNJ) stake by 3.4% in Q1 2026, selling an estimated $69.9K and leaving 8,600 shares worth $2.1M. The position accounts for 1.54% of the portfolio, ranked #17.

Rahlfs Capital first reported a position in JNJ in Q4 2024 and has held it in 6 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Rahlfs Capital held 8,600 shares of Johnson & Johnson worth $2.1M as of Q1 2026.
  • Rahlfs Capital sold 300 Johnson & Johnson shares in Q1 2026, an estimated $69.9K.
  • Johnson & Johnson made up 1.54% of Rahlfs Capital's portfolio in Q1 2026, its #17 holding.
  • Rahlfs Capital first reported a position in Johnson & Johnson in Q4 2024 and has held it in 6 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Rahlfs Capital's 13F filing for Q1 2026, filed 11 May 2026.